Skip to content
StockMarketAgent
Direct answer
ORCL trades against a final fair-value range of $188.36-$282.14, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs. Fair value range: low $188, high $282, with mid-point at $234.
Stock analysis

ORCL fair value $188–$282

By StockMarketAgent.AI team· supervised by
Przeanalizowano: 2026-05-07Następna aktualizacja: 2026-08-07Methodology v2.5Review: automatedArchetype: Mature compounder
View archive
Cena
$194.59
▲ +39.43 (+20.26%)
Wartość godziwa
$234
$188–$282
Rekomendacja
Kupuj
confidence 88/100
Potencjał wzrostu
+20.3%
upside to fair value
Margines Bezpieczeństwa
$198.92
MoS level · 15%
Kapitalizacja
$559.6B
P/E fwd 24.2
Awaryjny angielskiPL
Pokazujemy źródło angielskie podczas tłumaczenia
Ten raport nie został jeszcze przetłumaczony. Odśwież za kilka minut, gdy kolejka tłumaczeń go przetworzy.

§1 Podsumowanie wykonawcze

  • Composite fair value $234 with high case $282.
  • Implied upside of 20.3% to fair value.
  • Moat 9/10 · confidence 88/100 · Mature compounder.
  • Trades below fair value with a meaningful cushion to the midpoint.
Fair value
$234
Margin of safety
+16.8%
Confidence
88/100
Moat
9/10

Educational research only - not investment advice, an offer, or a trade instruction. Confirm current data and do your own due diligence before acting.

$194.59Price
Low $188.36
Mid $234.02
High $282.14

ORCL trades against a final fair-value range of $188.36-$282.14, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs.

  • Massive, sticky enterprise database install
    Massive, sticky enterprise database install base with extreme switching costs.
  • Integrated Generation 2 Cloud (OCI)
    Integrated Generation 2 Cloud (OCI) capturing emerging AI workloads.
  • Bull thesis
    Valuation models heavily favor forward-looking earnings over the near-term FCF distortion caused by AI CapEx.

§2 Scenariusz negatywny

A heavy capital expenditureCapital expendituresCash spent on acquiring or upgrading property, plant, and equipment. Splits into maintenance capex (sustaining current capacity) and growth capex (expanding capacity). cycle yields lower-than-expected ROICROICReturn on invested capital. Operating profit (after tax) divided by invested capital. The single best gauge of capital-efficiency. Spread over WACC = economic value created.. FCFFree cash flowOperating cash flow minus capital expenditures. The cash a business generates after maintaining and growing its asset base — the closest accounting proxy for owner-economics. remains severely depressed as CapExCapital expendituresCash spent on acquiring or upgrading property, plant, and equipment. Splits into maintenance capex (sustaining current capacity) and growth capex (expanding capacity). scales, while legacy on-premise revenueRevenueRevenue is an income-statement line item used to reconcile revenue to operating profit, pre-tax income, net income, or per-share earnings. It should be compared across periods and against peer disclosure conventions. deteriorates faster than OCI growth can offset, stressing the $104B debt load.

Jak ta teza może się załamać

Hyperscaler Margin War

· Medium

Dominant hyperscalers aggressively slash AI workload pricing, permanently compressing OCI's structural gross margins.

FV impact
-25%
Trigger
12-24 Months

Debt Overhang Paralysis

· Low

Prolonged high interest rates combined with $104B in debt restricts operational agility and forces dilutive equity raises.

FV impact
-15%
Trigger
24-36 Months

Accelerated Legacy Attrition

· Low

Enterprise customers migrate off legacy Oracle databases to cheaper, cloud-native open-source alternatives faster than anticipated.

FV impact
-30%
Trigger
24-48 Months
Sygnały wczesnego ostrzegania do monitorowania
WskaźnikBieżącyPróg wyzwalania
OCI revenue growth decelerating below 25% year-over-year.MonitorDeterioration versus the report thesis
Cloud infrastructure gross margin contracting by over 200 bps.MonitorDeterioration versus the report thesis
CapEx-to-revenue ratio remaining above 20% well beyond the peak AI buildout.MonitorDeterioration versus the report thesis
Net debt-to-EBITDA ratio exceeding 4x.MonitorDeterioration versus the report thesis
Failure to realize guided Cerner integration synergies.MonitorDeterioration versus the report thesis

§3 Historia finansowa

Rachunek zysków i strat — ostatnich sześć okresów

Pozycja2022-05-312023-05-312024-05-312025-05-31Trend
Przychody$42.44B$49.95B+17.7%$52.96B+6.0%$57.40B+8.4%+10.6%
Zysk brutto$33.56B$36.39B$37.82B$40.47B+6.4%
Zysk operacyjny$15.83B$13.77B$16.07B$18.05B+4.5%
Zysk netto$6.72B$8.50B+26.5%$10.47B+23.2%$12.44B+18.8%+22.8%
EPS (rozwodniony)$2.41$3.07$3.71$4.34+21.7%
EBITDA$13.53B$18.74B$21.39B$23.91B+20.9%
R&D$7.22B$8.62B$8.92B$9.86B+11.0%
SG&A$9.36B$10.41B$9.82B$10.25B+3.1%

Wyniki jakości

Wskaźnik Piotroski F
5 / 9
Złożony wynik jakości 0–9
Wskaźnik Altman Z
2.41
Ryzyko upadłości (>3 bezpieczne)
Wskaźnik Beneish M
-2.56
Ryzyko manipulacji wynikami
OCF / Zysk netto
1.67×
>1 wskazuje wysoką jakość wyników
Bramka jakości księgowej
Pass
Bramka skorygowana o sektor
ROIC
10.6%
Zwrot z zainwestowanego kapitału
Subskrybenci indywidualni — od §411 kolejnych sekcji

Przeczytaj pełną analizę — 11 kolejnych sekcji.

Competitive moat, industry cycle, peer comparison, intrinsic valuation, sensitivity, scenarios, earnings decision tree, position management, investor perspectives, scorecard, and final recommendation.

Pełny raport dla każdego pokrytego tickera
24 miesiące archiwum rekomendacji
Briefingi watchlisty + alerty zmian rekomendacji
Eksport PDF + DOCX w dowolnym języku
Rozpocznij darmowy okres próbny
Anuluj w dowolnym momencie.
REVENUE FAQ

ORCL revenue questions

  1. ORCL (ORCL)'s revenue growth is reported year-over-year across the most recent five fiscal years, with the deceleration or acceleration curve called out in the numbers-analysis subsection of the parent financials tab.
FAQ

ORCL — frequently asked questions

  1. Based on our latest analysis, ORCL looks meaningfully undervalued. The current price is $195 versus a composite fair-value midpoint of $234 (range $188–$282), which implies roughly 20.3% upside to the midpoint.
Related coverage

Names readers of ORCL also follow

Same archetype: mature-compounder